Discontinuation Order of Vasopressors in Septic Shock

• Status: Terminated
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the incidence of hypotension based on the discontinuation order of norepinephrine and vasopressin in patients receiving concomitant norepinephrine and vasopressin infusions for the treatment of septic shock.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Samsung Medical Center
• Treatments: Arginine Vasopressin; Norepinephrine; Vasoconstrictor Agents; Vasopressins

Criteria

Inclusion Criteria:

• patients 20 years of age or older

• patients of receiving concomitant therapy with norepinephrine and vasopressin for teh management of septic shock

• patients began to reduce the vasopressor

Exclusion Criteria:

• patients who expired or had care withdrawn while receiving norepinephrine and vasopressin

• patients being transferred into the ICU from an outside facility or the operating room

• patients who are suspected to have vasopressin deficiency (eg. HPA axis dysfunction, empty sella)

• acute myocardial infarction or Congestive heart failure (NYHA functional classification III or IV)

• acute mesenteric ischemia

• patients who were received other vasopressor except for norepinephrine or vasopressin